These studies tested whether antigenic competition between T cells occurs. We generated CD8+ T cell responses in H-2b mice against the dominant ovalbumin epitope SIINFEKL (ova8) and subdominant epitope KRVVFDKL, using either vaccinia virus expressing ovalbumin (VV-ova) or peptide-pulsed dendritic cells. CD8+ T cell responses were visualized by major histocompatibility complex class I–peptide tetrameric molecules. Transfer of transgenic T cells with high affinity for ova8 (OT1 T cells) completely inhibited the response of host antigen-specific T cells to either antigen, demonstrating that T cells can directly compete with each other for response to antigen. OT1 cells also inhibited CD8+ T cell responses to an unrelated peptide, SIYRYGGL, providing it was presented on the same dendritic cells as ova8. These inhibitions were not due to a more rapid clearance of virus or antigen-presenting cells (APCs) by the OT1 cells. Rather, the inhibition was caused by competition for antigen and antigen-bearing cells, since it could be overcome by the injection of large numbers of antigen-pulsed dendritic cells. These results imply that common properties of T cell responses, such as epitope dominance and secondary response affinity maturation, are the result of competitive interactions between antigen-bearing APC and T cell subsets.
Skip Nav Destination
Article navigation
16 October 2000
Article|
October 09 2000
T Cells Compete for Access to Antigen-Bearing Antigen-Presenting Cells
Ross M. Kedl,
Ross M. Kedl
aCancer Research Institute, Denver, Colorado 80206
cDepartment of Immunology, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver, Colorado 80206
Search for other works by this author on:
William A. Rees,
William A. Rees
cDepartment of Immunology, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver, Colorado 80206
Search for other works by this author on:
David A. Hildeman,
David A. Hildeman
bHoward Hughes Medical Institute, Denver, Colorado 80206
Search for other works by this author on:
Brian Schaefer,
Brian Schaefer
bHoward Hughes Medical Institute, Denver, Colorado 80206
Search for other works by this author on:
Tom Mitchell,
Tom Mitchell
cDepartment of Immunology, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver, Colorado 80206
Search for other works by this author on:
John Kappler,
John Kappler
bHoward Hughes Medical Institute, Denver, Colorado 80206
cDepartment of Immunology, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver, Colorado 80206
eDepartment of Pharmacology, Denver, Colorado 80206
fDepartment of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206
Search for other works by this author on:
Philippa Marrack
Philippa Marrack
bHoward Hughes Medical Institute, Denver, Colorado 80206
cDepartment of Immunology, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver, Colorado 80206
dDepartment of Biochemistry and Molecular Genetics, Denver, Colorado 80206
fDepartment of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206
Search for other works by this author on:
Ross M. Kedl
aCancer Research Institute, Denver, Colorado 80206
cDepartment of Immunology, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver, Colorado 80206
William A. Rees
cDepartment of Immunology, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver, Colorado 80206
David A. Hildeman
bHoward Hughes Medical Institute, Denver, Colorado 80206
Brian Schaefer
bHoward Hughes Medical Institute, Denver, Colorado 80206
Tom Mitchell
cDepartment of Immunology, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver, Colorado 80206
John Kappler
bHoward Hughes Medical Institute, Denver, Colorado 80206
cDepartment of Immunology, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver, Colorado 80206
eDepartment of Pharmacology, Denver, Colorado 80206
fDepartment of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206
Philippa Marrack
bHoward Hughes Medical Institute, Denver, Colorado 80206
cDepartment of Immunology, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver, Colorado 80206
dDepartment of Biochemistry and Molecular Genetics, Denver, Colorado 80206
fDepartment of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206
Abbreviations used in this paper: β2M, β2-microglobulin; B6, C57BL/6J; B6.PL, B6.PL-Thy1a/Cy; DC, dendritic cell; GFP, green fluorescent protein; NP, nucleoprotein; SA-PE, PE-labeled streptavidin; VV, vaccinia virus.
Received:
April 21 2000
Revision Requested:
July 11 2000
Accepted:
July 24 2000
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Exp Med (2000) 192 (8): 1105–1114.
Article history
Received:
April 21 2000
Revision Requested:
July 11 2000
Accepted:
July 24 2000
Citation
Ross M. Kedl, William A. Rees, David A. Hildeman, Brian Schaefer, Tom Mitchell, John Kappler, Philippa Marrack; T Cells Compete for Access to Antigen-Bearing Antigen-Presenting Cells. J Exp Med 16 October 2000; 192 (8): 1105–1114. doi: https://doi.org/10.1084/jem.192.8.1105
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement